血栓通治疗慢性阻塞性肺疾病急性加重期的疗效分析

Therapeutic Effect of Xueshuantong on Acute Exacerbation of Chronic Obstructive Pulmonary Disease

目的研究分析临床中血栓通治疗慢阻肺急性加重期患者的治疗效果及影响。方法回顾分析2016年4月—2018年5月期间于本院就诊的96例患者开展临床研究,根据患者治疗药物的选择将其分为常规组与实验组,各48例。常规组接受传统西药治疗,实验组在常规组治疗基础上联合血栓通治疗,对比两组治疗前后的肺功能、血气指标变化情况及临床疗效。结果治疗后,较治疗前两组肺功能及部分血气指标均有改善,差异有统计学意义(P<0.05);且实验组临床疗效优于对照组,差异有统计学意义(P<0.05)。结论血栓通在慢阻肺急性期临床治疗中的治疗优势显著,可在临床中治疗中予以应用。

Objective To study and analyze the therapeutic effect and influence of Xueshuantong on acute exacerbation of chronic obstructive pulmonary disease(COPD).Methods A retrospective analysis was made of 96 patients who were treated in our hospital from April 2016 to May 2018.According to the choice of treatment drugs,the patients were divided into routine group and experimental group,48 cases in each group.The routine group was treated with traditional western medicine,while the experimental group was treated with Xueshuantong on the basis of routine treatment.The changes of pulmonary function,blood gas index and clinical efficacy of the two groups before and after treatment were compared.Results After treatment,the pulmonary function and part of blood gas indexes of the two groups were improved compared with those before treatment,with statistical significance(P<0.05);and the clinical efficacy of the experimental group was better than that of the control group,with statistical significance(P<0.05).Conclusion Xueshuantong has a significant advantage in the treatment of acute chronic obstructive pulmonary disease and can be used in clinical treatment.